NPR logo

FDA Approves ImClone Cancer Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1673112/1673113" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
FDA Approves ImClone Cancer Drug

Science

FDA Approves ImClone Cancer Drug

FDA Approves ImClone Cancer Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1673112/1673113" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration approves Erbitux, a colon cancer drug made by ImClone. The drug is at the center of the insider-trading trial of Martha Stewart. Stewart's sale of shares in the company occurred shortly after ImClone received a letter from the FDA saying Erbitux would not be approved. NPR's Snigdha Prakash reports.